TY - JOUR
T1 - In Situ Printing of Adhesive Hydrogel Scaffolds for the Treatment of Skeletal Muscle Injuries
AU - Russell, Carina S.
AU - Mostafavi, Azadeh
AU - Quint, Jacob P.
AU - Panayi, Adriana C.
AU - Baldino, Kodi
AU - Williams, Tyrell J.
AU - Daubendiek, Jocelyn G.
AU - Hugo Sánchez, Victor
AU - Bonick, Zack
AU - Trujillo-Miranda, Mairon
AU - Shin, Su Ryon
AU - Pourquie, Olivier
AU - Salehi, Sahar
AU - Sinha, Indranil
AU - Tamayol, Ali
N1 - Publisher Copyright:
© 2020 American Chemical Society.
PY - 2020/3/16
Y1 - 2020/3/16
N2 - Reconstructive surgery remains inadequate for the treatment of volumetric muscle loss (VML). The geometry of skeletal muscle defects in VML injuries varies on a case-by-case basis. Three-dimensional (3D) printing has emerged as one strategy that enables the fabrication of scaffolds that match the geometry of the defect site. However, the time and facilities needed for imaging the defect site, processing to render computer models, and printing a suitable scaffold prevent immediate reconstructive interventions post-traumatic injuries. In addition, the proper implantation of hydrogel-based scaffolds, which have generated promising results in vitro, is a major challenge. To overcome these challenges, a paradigm is proposed in which gelatin-based hydrogels are printed directly into the defect area and cross-linked in situ. The adhesiveness of the bioink hydrogel to the skeletal muscles was assessed ex vivo. The suitability of the in situ printed bioink for the delivery of cells is successfully assessed in vitro. Acellular scaffolds are directly printed into the defect site of mice with VML injury, exhibiting proper adhesion to the surrounding tissue and promoting remnant skeletal muscle hypertrophy. The developed handheld printer capable of 3D in situ printing of adhesive scaffolds is a paradigm shift in the rapid yet precise filling of complex skeletal muscle tissue defects.
AB - Reconstructive surgery remains inadequate for the treatment of volumetric muscle loss (VML). The geometry of skeletal muscle defects in VML injuries varies on a case-by-case basis. Three-dimensional (3D) printing has emerged as one strategy that enables the fabrication of scaffolds that match the geometry of the defect site. However, the time and facilities needed for imaging the defect site, processing to render computer models, and printing a suitable scaffold prevent immediate reconstructive interventions post-traumatic injuries. In addition, the proper implantation of hydrogel-based scaffolds, which have generated promising results in vitro, is a major challenge. To overcome these challenges, a paradigm is proposed in which gelatin-based hydrogels are printed directly into the defect area and cross-linked in situ. The adhesiveness of the bioink hydrogel to the skeletal muscles was assessed ex vivo. The suitability of the in situ printed bioink for the delivery of cells is successfully assessed in vitro. Acellular scaffolds are directly printed into the defect site of mice with VML injury, exhibiting proper adhesion to the surrounding tissue and promoting remnant skeletal muscle hypertrophy. The developed handheld printer capable of 3D in situ printing of adhesive scaffolds is a paradigm shift in the rapid yet precise filling of complex skeletal muscle tissue defects.
KW - adhesive hydrogels
KW - bioinks
KW - gelatin methacryloyl
KW - in situ printing
KW - skeletal muscle injury
UR - http://www.scopus.com/inward/record.url?scp=85080120823&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080120823&partnerID=8YFLogxK
U2 - 10.1021/acsabm.9b01176
DO - 10.1021/acsabm.9b01176
M3 - Article
C2 - 35021647
AN - SCOPUS:85080120823
SN - 2576-6422
VL - 3
SP - 1568
EP - 1579
JO - ACS Applied Bio Materials
JF - ACS Applied Bio Materials
IS - 3
ER -